| Sheldon Family Chiropractic | |
|
96 N Main St Ste 103 Cedar City UT 84720-3055 | |
| (435) 867-8986 | |
| (435) 867-6233 |
| Full Name | Sheldon Family Chiropractic |
|---|---|
| Speciality | Clinic/Center |
| Location | 96 N Main St, Cedar City, Utah |
| Authorized Official Name and Position | Dean Foster Sheldon (OWNER) |
| Authorized Official Contact | 4358678986 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Sheldon Family Chiropractic 96 N Main St Ste 103 Cedar City UT 84720-3055 Ph: (435) 867-8986 | Sheldon Family Chiropractic 96 N Main St Ste 103 Cedar City UT 84720-3055 Ph: (435) 867-8986 |
| NPI Number | 1073954467 |
|---|---|
| Provider Enumeration Date | 07/13/2013 |
| Last Update Date | 10/29/2013 |
| Medicare PECOS PAC ID | 4486889995 |
|---|---|
| Medicare Enrollment ID | O20131108000174 |
News Archive
The mosquito-borne virus chikungunya may lead to severe brain infection and even death in infants and people over 65, according to a new study that reviewed a chikungunya outbreak on Reunion Island off the coast of Madagascar in 2005-2006.
"A new Cochrane Systematic Review examines the accuracy of Rapid Diagnostic Tests (RDTs), which are designed to detect malaria based on the presence of parasite antigens, using a quick and easy to use format," according to a press release issued by Wiley.
IAOCR, the leading provider of independently recognized, competence-based accreditation, consultancy and accredited training within the clinical research sector, is pleased to announce the pilot Clinical Operations Workforce Quality Accreditation, achievement of which will serve as a quality mark for clinical operations workforce excellence. Leading contract research organization (CRO) INC Research is the first to participate in the pilot, introduced to industry specialists at the annual IAOCR Clinical Research Industry Leaders Think Tank in June.
A new study of the safety of the tetanus-diphtheria-acellular pertussis (Tdap) vaccine supports the recommendation that those 65 and older get the vaccine to protect themselves and others, particularly young babies, from pertussis.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the Biologic License Application (BLA) for Neutroval™ (granulocyte colony-stimulating factor) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073954467 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | 8714152-0162 (Utah) | Primary |
| Provider Name | Dean Foster Sheldon |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1659608032 PECOS PAC ID: 6800923723 Enrollment ID: I20131108000249 |
News Archive
The mosquito-borne virus chikungunya may lead to severe brain infection and even death in infants and people over 65, according to a new study that reviewed a chikungunya outbreak on Reunion Island off the coast of Madagascar in 2005-2006.
"A new Cochrane Systematic Review examines the accuracy of Rapid Diagnostic Tests (RDTs), which are designed to detect malaria based on the presence of parasite antigens, using a quick and easy to use format," according to a press release issued by Wiley.
IAOCR, the leading provider of independently recognized, competence-based accreditation, consultancy and accredited training within the clinical research sector, is pleased to announce the pilot Clinical Operations Workforce Quality Accreditation, achievement of which will serve as a quality mark for clinical operations workforce excellence. Leading contract research organization (CRO) INC Research is the first to participate in the pilot, introduced to industry specialists at the annual IAOCR Clinical Research Industry Leaders Think Tank in June.
A new study of the safety of the tetanus-diphtheria-acellular pertussis (Tdap) vaccine supports the recommendation that those 65 and older get the vaccine to protect themselves and others, particularly young babies, from pertussis.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the Biologic License Application (BLA) for Neutroval™ (granulocyte colony-stimulating factor) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.
› Verified 3 days ago
News Archive
The mosquito-borne virus chikungunya may lead to severe brain infection and even death in infants and people over 65, according to a new study that reviewed a chikungunya outbreak on Reunion Island off the coast of Madagascar in 2005-2006.
"A new Cochrane Systematic Review examines the accuracy of Rapid Diagnostic Tests (RDTs), which are designed to detect malaria based on the presence of parasite antigens, using a quick and easy to use format," according to a press release issued by Wiley.
IAOCR, the leading provider of independently recognized, competence-based accreditation, consultancy and accredited training within the clinical research sector, is pleased to announce the pilot Clinical Operations Workforce Quality Accreditation, achievement of which will serve as a quality mark for clinical operations workforce excellence. Leading contract research organization (CRO) INC Research is the first to participate in the pilot, introduced to industry specialists at the annual IAOCR Clinical Research Industry Leaders Think Tank in June.
A new study of the safety of the tetanus-diphtheria-acellular pertussis (Tdap) vaccine supports the recommendation that those 65 and older get the vaccine to protect themselves and others, particularly young babies, from pertussis.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the Biologic License Application (BLA) for Neutroval™ (granulocyte colony-stimulating factor) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.
› Verified 3 days ago
North Family Practice, P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 55 E Canyon Commercial Ave, Cedar City, UT 84720 Phone: 435-867-8050 Fax: 435-867-8083 | |
D/b/a Family Healthcare Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 245 East 680 South, Family Healthcare Center East Clinic, Cedar City, UT 84720 Phone: 435-865-1387 Fax: 435-865-6357 | |
Steven C Taggart Od Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1330 S Providence Center Dr, Cedar City, UT 84720 Phone: 435-865-2809 | |
Cedar City Chiropractic And Rehabilitation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1180 Sage Dr Ste E, Cedar City, UT 84720 Phone: 435-867-6354 | |
Advanced Family Health Care, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1760 N Main St, Suite 103, Cedar City, UT 84721 Phone: 435-867-0644 | |
Southern Utah Sports Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 110 W 1325 N, Cedar City, UT 84721 Phone: 435-868-6180 |